Navigation Links
Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference
Date:3/30/2011

TARRYTOWN, N.Y., March 30, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the 10th Annual Needham Healthcare Conference on Wednesday, April 6, 2011 at 1:20 p.m. Eastern Time.  The session may be accessed through the Company's web site, www.regeneron.com, on the Investor Relations page.  An archived version of the presentation will be available after the live webcast through May 6, 2011.  

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.  In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com. Contact Information:Michael Aberman, M.D.

Peter DworkinInvestor Relations

Corporate Communications914.345.7799

914.345.7640michael.aberman@regeneron.com

peter.dworkin@regeneron.com
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
2. Regeneron Announces March 2011 Investor Conference Presentations
3. Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
4. Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
5. Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
6. Regeneron Announces Presentation at the ISI Annual Conference
7. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
8. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
9. Christine A. Poon Elected to Regeneron Board of Directors
10. Regeneron Announces Presentation at the 2010 Credit Suisse Annual Healthcare Conference
11. Regeneron Announces Presentation at the 17th Annual NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... UHC has released the findings of a new study ... cost and quality outcomes to uncover several trends related ... utilization of PPIs—which can account for 30% to 40% ... medical centers, focusing on procedures utilizing orthopedic implants, coronary ... The study, begun in 2013, integrated the pilot test ...
(Date:3/31/2015)... , March 31, 2015 Point-of-Care ... and management consulting firm, has launched the ePA ... enable health IT vendors, payers and pharmacies to ... electronic prior authorization (ePA) of prescription medications. ... (PA) requests are completed through time-consuming, manual processes ...
(Date:3/31/2015)... 31, 2015  The efficacy of continuous UV-C disinfection ... recently published study 1 of ultraviolet (UV) light ... including Curtis Donskey , M.D.  The study tested ... same length of time from the same point in ... results showed surprisingly low pathogen kill rates for the ...
Breaking Medicine Technology:UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Point-of-Care Partners Launches the ePA State Navigator 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4
... MiMedx Group, Inc. (OTCBB: MDXG), an integrated ... products and bioimplants processed from human amniotic membrane, ... the Company,s latest biologic implant processed to offer ... Produced from the MiMedx Group,s proprietary Purion® ...
... Cardinal Health today announced that its board of directors has approved ... per share, or $0.86 per share on an annualized basis. ... shareholders of record on July 1. Cardinal Health has paid a ... This marks the 107th consecutive regular quarterly dividend for Cardinal Health. ...
Cached Medicine Technology:MiMedx Announces Launch of AmnioFix™ Nerve Wrap 2Cardinal Health Raises Quarterly Dividend By 10 Percent 2Cardinal Health Raises Quarterly Dividend By 10 Percent 3
(Date:3/31/2015)... 2015 Dr. Parsa Mohebi, founder of Parsa Mohebi ... on the forefront of using beard hair to fill ... as a novelty has now become an absolute option for giving ... “I really do believe that beard to scalp hair transplant can ... donor area isn’t as dense as we would like it,” says ...
(Date:3/31/2015)... Calling all runners, walkers and everyone who wants to join ... annual “Lyme Walk & Run” will be held Sunday, April ... hosted by Lyme Research Alliance (LRA) & Tick-Borne ... and education about Lyme and other tick-borne diseases. , ... feature 5K and 10K runs and one-mile and three-mile Walks ...
(Date:3/31/2015)... Santa Clara, CA (PRWEB) March 31, 2015 ... Devices (IPD), has introduced a wire-bondable silicon ESD diode chip ... range of bare-die diode offerings, these Zeners are ideal for ... The ESD2117 diode can handle pulses of up ... to level 4 of the IEC 61000-4-2 standard. These ...
(Date:3/31/2015)... March 31, 2015 Dr. ... by the American Board of Dermatology and fellowship ... research training at the National Cancer Institute of ... his internship in internal medicine at the Emory ... Pennsylvania in Philadelphia. Dr. Li pursued further training ...
(Date:3/31/2015)... Dr. Uzma Parvez is having a busy start ... Grand Grounds Presentations at St. Michael’s Medical Center for attending ... The event was attended by a large gathering of ... feedback from the Grand Rounds. It was said that ... a while. , Ahead, Dr. Parvez has been invited ...
Breaking Medicine News(10 mins):Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:OnChip Introduces Low Voltage Diodes for High-Brightness LED Protection 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2
... ... Brilliance Weight Loss, has now launched to help take the guesswork and frustration out of losing ... lose weight and gain better health. , ... Seattle, WA (PRWEB) June 17, 2010 -- The battle of lasting weight loss is ...
... ... pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will join ENTA in ... ... (ENTA) is pleased to announce the addition of Brian Safier, MD, Allergist/Immunologist, who will join ...
... Ellsworth Adhesives ... Ellsworth Adhesives S. de R.L. de C.V. (Mexico). , ... Germantown, WI (PRWEB) June 17, 2010 -- Ellsworth Adhesives is ... Adhesives S. de R.L. de C.V. (Mexico). In his new role, Lázaro will focus ...
... benign neoplasm with locally aggressive behavior but malignant change is ... with clinical presentations of abdominal pain and body weight loss ... be published on June 7, 2010 in the World ... led by Professor Ko from Chang Gung University College of ...
... Rome, Italy, Thursday 17 June 2010: Biologics-nave Juvenile Idiopathic ... cancer compared with the general Swedish population, according to ... of the European League Against Rheumatism in Rome, Italy. ... cohort of patients showed an increased frequency of cancer ...
... The AACC 2010 Annual ... company plans to unveil several new products, host giveaways and provide live demonstrations of Tosoh,s advanced ... ... be an exciting event for Tosoh Bioscience (Booth #7714) as the company plans to unveil ...
Cached Medicine News:Health News:Brilliance Weight Loss Will Give You the Tools for Effective Weight Loss 2Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 2Health News:ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier, 3Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:Biologics-naive juvenile idiopathic arthritis patients have elevated risk of cancer 2Health News:AACC 2010 Creates Excitement for Tosoh Immunoassay and HPLC Analyzers 2
... Air-Stirrup Ankle Brace has been the "standard ... ankle injuries and has been cited in ... performance in helping to heal ankle injuries.,Each ... lined with the patented Duplex™ aircell system. ...
... Cryo/Cuff combines the therapeutic benefits of controlled ... cold to minimize pain. The cuff is ... providing maximum cryotherapy. The Ankle Cryo/Cuff is ... in a pediatric size.,All Cryo/Cuffs can be ...
... Plus combines the clinically proven Air-Stirrup ... In addition, a comprehensive instruction booklet ... and provides information on treatment and ... sprain management.,Each Air-Stirrup Ankle Brace features ...
... exclusively with the Aircast VenaFlow System (a ... in three different styles: calf, foot, and ... cuff is made from light, cool, comfortable ... the cuff may be placed directly against ...
Medicine Products: